The Patent Finder

MicroRNA-Based Methods and Assays for Osteosarcoma

3-D Matrix, Ltd.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application PCT/IB2012/002626, filed Sep 7, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,905,708Microrna-Based Methods and Assays for Osteocarcinoma
In force
 · High confidence
3-D Matrix, Ltd.In force
High confidence
US 11,260,072MicroRNA-based methods and assays for osteocarcinoma
In force
 · High confidence
3-D Matrix, Ltd.In force
High confidence
US 9,322,016MicroRNA-Based Methods and Assays for Osteosarcoma
In force
 · High confidence
3-D Matrix, Ltd.In force
High confidence
Application 15/096,480MicroRNA-Based Methods and Assays for Osteosarcoma
Abandoned
Abandoned Aug 5, 2019
3-D Matrix, Ltd.AbandonedAbandoned Aug 5, 2019
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by 3-D Matrix, Ltd..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited